The Deputy Director of the National Medical Products Administration met with the Deputy Director of the FDA, stating that both sides will continue to carry out pragmatic cooperation
Yang Sheng, Deputy Director of the National Medical Products Administration of China, met with Yang Du, Deputy Director of the FDA of the United States. Both sides affirmed the effectiveness of China-U.S. pharmaceutical regulatory cooperation and expressed their intention to continue practical cooperation to promote more high-quality products benefiting the people of both countries. The Chinese side introduced the latest developments in drug regulation and the review of the Implementation Regulations of the Drug Administration Law, while the U.S. side reported on key work such as ensuring the pharmaceutical supply chain, regulating digital health products, and managing the quality of medical devices, and engaged in in-depth exchanges on drug import and export policies, pharmacovigilance, and the application of new methodologies
AASTOCKS·
